The NHS or National Health Service is the name used for the UK’s public health service. It was established in 1948 as one of the major social reforms decided after the Second World War. it was founded upon these main principles. That the services should be comprehensive, universal and free. UK residents are not charged for the treatment they receive. Citizens within the EU containing a European Heath Card can receive emergency treatment at no cost. Along with persons from countries with which the UK has reciprocal arrangements concerning health care.
Funding
The funding of the NHS comes 98.8 percent from general taxation and National Insurance contributions along with donations. The 2008/9 budget roughly equates to a contribution of £1,980 per person in the UK. When Launched the NHS budget was around £437 million however it received more than £100 billion in 2008/2009. 60 percent of the NHS budget is used to pay staff. With a further 20 percent paying for drugs and other supplies.
Gino Martini, RPS Chief Scientist and the Science and Research Team at the Royal Pharmaceutical Society reflect on the role of pharmacy during COVID-19 in delivering accessible, safe and effective care for all.
The NHS have completed the largest public sector migration to a new data network - meaning that organisations will have a better connectivity at a better cost.
Professor Mike Barnes, Co-Founder of Maple Tree Consultancy states that the UK’s clinicians need training in medical cannabis and explains precisely why this should be.
US and UK researchers examined ethnicity data in both countries, finding that Black and Asian people were twice as likely as white people to be infected by the virus - but why?
Hannah Deacon, Co-Founder of Maple Tree Consultancy and Campaigner ponders if the UK’s post-COVID-19 economy can benefit from a booming medical cannabis industry.
Stephen Jones, CEO and Co-Founder at Nourish Fit Food, discusses how Britain's obesity plan will continue to fail unless the concept of health itself is radically redefined.
With only 2 months to go, Nicholas Kelly, CEO, Axela Ltd, discusses what needs to be done now in order to prepare healthcare services for the post-Brexit era.
Researchers from the Health Economics Unit and University of Leeds looked at the cost of treating strokes and found that the drugs prescribed are so effective they save the NHS money.
A study by the Bloomberg School of Public Health found that severe COVID-19 patients can produce strong antibodies for vaccine testing - especially the older male population.
Richard Armstrong, head of health registries at Northgate Public Services, examines the growing importance of medical registries in a health crisis and why some programmes are destined to fail patients.
Danny Bluestone, CEO of Cyber-Duck, stresses the importance of creating an accessible digital presence that is designed to put the user at the heart of the experience, particularly within governments.
